Item 2.02  Results of Operations and Financial Condition.
On November 9, 2021, Pliant Therapeutics, Inc. (the "Company") issued a press
release announcing the Company's financial results for the third quarter ended
September 30, 2021. A copy of this press release is furnished as Exhibit 99.1 to
this report and incorporated herein by reference.
The information in this Current Report on Form 8-K including the exhibits
furnished herewith shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934 (as amended, the "Exchange Act") or otherwise
subject to the liabilities of that Section, and shall not be or be deemed to be
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, regardless of any general incorporation language
in such filing.
Item 9.01   Financial Statements and Exhibits.
(d) Exhibits.
   Exhibit
     No.             Description
     99.1              Press Release issued by the Company dated     November     9, 2021.


                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses